--(BUSINESS WIRE)--BIOCRATES Life Sciences AG is a leading metabolomics company using a mass-spectrometry based technology platform. Biocrates’ quantitative approach delivers immediate identification of metabolites, measurement of their absolute concentrations, and mapping to their respective pathways. Biocrates’ TargetIDQ™ Services provide customers direct access to Biocrates’ expertise, enabling identification and quantification of hundreds of metabolites from a broad range of samples, ultimately revealing meaningful biomarkers. In addition to offering services, Biocrates is the only company offering the AbsoluteIDQ™ p150 Kit, allowing customers to measure and identify more than a 150 metabolites in over 4 compound classes from their valuable clinical and pre-clinical samples in just a few minutes per sample.
